First Cited
Last Cited

Articles citing This Document (Page 1 of 9)

Synoptic CT scan reporting of pancreatic adenocarcinoma to align with international consensus guidelines on surgical resectability: a Victorian pilot
Neoadjuvant chemotherapy or upfront surgery in localized pancreatic cancer: a contemporary analysis2022
Prognostic factors in conversion surgery following nab‐paclitaxel with gemcitabine and subsequent chemoradiotherapy for unresectable locally advanced pancreatic cancer: Results of a dual‐center study
Stereotactic Body Radiotherapy for Locally Advanced Pancreatic Cancer Using Optical Surface Management System – AlignRT as an Optical Body Surface Motion Management in Deep Breath Hold Patients: Results from a Single-Arm Retrospective StudyCancer Management and Research
Precision Approaches to Pancreatic Cancer Therapy: What Now and What Next?Current Treatment Options in Gastroenterology
The Future Perspectives of Redefining the Resection Margin Status in Different Cancers of PancreasOpen Access Macedonian Journal of Medical Sciences2022
A Prospective Study of Neoadjuvant Gemcitabine Plus Nab-paclitaxel in Patients with Borderline-resectable Pancreatic CancerInternal Medicine2022
Adaptive Dynamic Therapy and Survivorship for Operable Pancreatic CancerJAMA Network Open2022
Patterns of disease relapse and posttreatment follow‐up of patients with resected pancreatic adenocarcinoma: A single‐center analysisJournal of Surgical Oncology
Proton Therapy in the Management of Pancreatic CancerCancers2022
Interdisciplinary Approach of Establishing PDAC Resectability: Biochemical, Radiological and NAT Regimen Prognostic Factors—Literature ReviewMedicina (Lithuania)2022
Prediction of Margin‐Negative Resection of Pancreatic Ductal Adenocarcinoma Following Neoadjuvant Therapy: Diagnostic Performance of NCCN Criteria for Resection vs. CT‐Determined ResectabilityJournal of Hepato-Biliary-Pancreatic Sciences
The influence of UGT1A1 polymorphisms on modified FOLFIRINOX dose in double-variant-type patients with advanced pancreatic cancerInternational Journal of Clinical Oncology
The Next Frontier in Pancreatic Cancer: Targeting the Tumor Immune Milieu and Molecular PathwaysCancers2022
Stereotactic Ablative Radiotherapy Using CALYPSO® Extracranial Tracking for Intrafractional Tumor Motion Management—A New Potential Local Treatment for Unresectable Locally Advanced Pancreatic Cancer? Results from a Retrospective StudyCancers2022
PET-CT in Clinical Adult Oncology: III. Gastrointestinal MalignanciesCancers2022
Nationwide trends and outcomes of neoadjuvant chemotherapy in pancreatic cancer – an analysis of the Swedish national pancreatic cancer registryScandinavian Journal of Gastroenterology
Distal Pancreatectomy with En Bloc Celiac Axis Resection2022
Pancreaticoduodenectomy with Splenic Artery Resection for Tumors of the Pancreatic Head and/or Body Invading the Splenic Artery2022
The short-term outcomes of distal pancreatectomy with portal vein/superior mesenteric vein resectionLangenbeck's Archives of Surgery
Real‐world staging computed tomography scanning technique and important reporting discrepancies in pancreatic ductal adenocarcinomaANZ Journal of Surgery
Downstaging of Pancreatic Adenocarcinoma With Either Neoadjuvant Chemotherapy or Chemoradiotherapy Improves Survival.Annals of Surgical Oncology2022
A multimodality review of solid and cystic pancreatic masses
Intraoperative Pancreatic Neck Margin Assessment During Pancreaticoduodenectomy for Pancreatic Adenocarcinoma in the Era of Neoadjuvant Therapy: A Multi-institutional Analysis from the Central Pancreatic Consortium.Annals of Surgical Oncology2022
Response: Impact of Tumor Size on Outcomes for Patients with Resectable Distal Pancreatic Cancer.Annals of Surgical Oncology2022
Pancreatic Ductal Cell-Derived Extracellular Vesicles Are Effective Drug Carriers to Enhance Paclitaxel's Efficacy in Pancreatic Cancer Cells through Clathrin-Mediated Endocytosis.International Journal of Molecular Sciences2022
Real-world outcomes of adjuvant gemcitabine gemcitabine plus capecitabine for resected pancreatic ductal adenocarcinoma.Therapeutic Advances in Medical Oncology2022
Ablative Radiotherapy (ART) for Locally Advanced Pancreatic Cancer (LAPC): Toward a New Paradigm?Life2022
Prognostic stratification in patients with pancreatic ductal adenocarcinoma after curative resection based on preoperative pancreatic contrast-enhanced CT findings.European Journal of Radiology2022
Prognosis following an extended duration of adjuvant gemcitabine plus S-1 chemotherapy in patients with pancreatic ductal adenocarcinoma: analysis using inverse probability of treatment weighting.Journal of Hepato-Biliary-Pancreatic Sciences2022
Modified FOLFIRINOX versus sequential chemotherapy (FOLFIRI/FOLFOX) as a second-line treatment regimen for unresectable pancreatic cancer: A real-world analysis.Cancer Medicine2021
The Association Between Neoadjuvant Therapy and Pathological Outcomes in Pancreatic Cancer Patients After Resection: Prognostic Significance of Microscopic Venous Invasion.Annals of Surgical Oncology2022
Induction therapy with Lu-DOTATATE procures long-term survival in locally advanced or oligometastatic pancreatic neuroendocrine neoplasm patients.European Journal of Nuclear Medicine and Molecular Imaging2022
ASO Author Reflections: The Survival Advantage Persists: Benefit of Adjuvant Chemotherapy in Resected, Stage IA Pancreatic Cancer.Annals of Surgical Oncology2022
Impact of the Cancer and Aging Research Group score and treatment intensity on survival and toxicity outcomes in older adults with advanced noncolorectal gastrointestinal cancers.Cancer2022
Deciphering the Etiology of Weight Loss Following Pancreatectomy.Annals of Surgical Oncology2022
Neoadjuvant Stereotactic Body Radiotherapy After Upfront Chemotherapy Improves Pathologic Outcomes Compared With Chemotherapy Alone for Patients With Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma Without Increasing Perioperative Toxicity.Annals of Surgical Oncology2022
Neoadjuvant Therapy Is Associated with Improved Chemotherapy Delivery and Overall Survival Compared to Upfront Resection in Pancreatic Cancer without Increasing Perioperative Complications.Cancers2022
Magnetic Resonance Imaging Radiomics-Based Nomogram From Primary Tumor for Pretreatment Prediction of Peripancreatic Lymph Node Metastasis in Pancreatic Ductal Adenocarcinoma: A Multicenter Study.Journal of Magnetic Resonance Imaging2022
Competing Risk Analysis of Outcomes of Unresectable Pancreatic Cancer Patients Undergoing Definitive Radiotherapy.Frontiers in Oncology2021
Molecular Features and Clinical Management of Hereditary Pancreatic Cancer Syndromes and Familial Pancreatic Cancer.International Journal of Molecular Sciences2022
Contemporary Assessment of Need for Palliative Bypass After Aborted Pancreatoduodenectomy Following Neoadjuvant Therapy.Journal of Gastrointestinal Surgery2022
MR-guided adaptive stereotactic body radiotherapy (SBRT) of primary tumor for pain control in metastatic pancreatic ductal adenocarcinoma (mPDAC): an open randomized, multicentric, parallel group clinical trial (MASPAC).Radiation Oncology2022
A novel event-free survival endpoint in locally advanced pancreatic cancerTherapeutic Advances in Medical Oncology2021
A novel method for predicting perineural invasion of distal cholangiocarcinoma on multidetector-row computed tomographySurgery Today2021
An Evaluation of Total Internal Motions of Locally Advanced Pancreatic Cancer during SABR Using Calypso Extracranial Tracking, and Its Possible Clinical Impact on Motion Management.Current Oncology2021
Real-world prognostic factors for survival among treated patients with metastatic pancreatic ductal adenocarcinomaCancer Medicine2021
Stereotactic Radiotherapy for Pancreatic Cancer: A Single-Institution ExperienceCureus2020
Staging of pancreatic cancer with multidetector CT in the setting of preoperative chemoradiation therapyAbdominal Imaging2006